DiaSorin S.p.A. (DIA)

DiaSorin develops and markets in vitro diagnostic systems and reagents, with a focus on immunodiagnostics and molecular diagnostics. Its automated platforms and specialty test menus are used by clinical laboratories for infectious disease, hormone, oncology and other specialty assays. The company is known for niche, high-value diagnostic tests rather than broad routine chemistry volumes.

Market
Borsa Italiana (Milan)
Sector
Healthcare
Trend
Strong uptrend
Last close
76.76 (+0.5% on the day)
MA50
72
MA200
67.01
52-week range
54.59–80.82
Market cap
3.8B EUR
P/E
28.07
Dividend yield
1.69%
Data as of
2026-09-03
Quarterly revenue and earnings, millions
QuarterRevenueYoY %EarningsYoY %
Q1 202531352
Q2 2025306.347.4

All markets — KeepWinning global stock screener

Other companies on Borsa Italiana (Milan): Iveco Group N.V. (IVG), ERG S.p.A. (ERG), Danieli & C. Officine Meccaniche S.p.A. (DANR), Iren SpA (IRE), Carel Industries S.p.A. (CRL), ENAV S.p.A. (ENAV)